Related Experiment Video
Updated: May 21, 2026
10:28
The Encapsulation of Cell-free Transcription and Translation Machinery in Vesicles for the Construction of Cellular Mimics
Published on: October 21, 2013
Unleashing a "true" pSer-mimic in the cell
Kaushik Panigrahi1, David L Nelson, David B Berkowitz
1Department of Chemistry, University of Nebraska, Lincoln, NE 68588-0304, USA.
Chemistry & Biology
|June 26, 2012
Summary
Researchers developed a novel prodrug for delivering a phosphoserine mimic into cells. This strategy triggers leukemic cell death by releasing a pro-apoptotic transcription factor.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- Developing effective intracellular drug delivery systems is crucial for cancer therapy.
- Prodrug strategies offer a way to improve drug targeting and reduce systemic toxicity.
- Phosphoserine mimics are of interest for their potential to modulate protein interactions.
Discussion:
- This study introduces a novel prodrug designed for intracellular delivery of a difluoromethylene phosphonate phosphoserine mimic.
- Upon intracellular deprotection, the pseudo-phosphopeptide releases the FOXO3a-transcription factor.
- This release disrupts the 14-3-3 adaptor protein complex, a key event in apoptosis induction.
Key Insights:
- A new prodrug strategy enables targeted intracellular delivery of a phosphoserine mimic.
- The prodrug effectively releases the FOXO3a-transcription factor, promoting apoptosis.
- This approach shows promise for inducing leukemic cell death.
Outlook:
- This prodrug strategy could be further explored for treating other cancers dependent on FOXO3a signaling.
- Optimization of the prodrug's chemical structure may enhance its efficacy and specificity.
- Further in vivo studies are warranted to assess the therapeutic potential of this approach.
